He Will Not Get Out of the Chair
It looks like giving up. It looks like laziness. It is neither, and treating it as either will cost you months of unnecessary anger.
Key takeaways
- Apathy is the most common neuropsychiatric symptom in dementia — around half of people with Alzheimer's, and it climbs steeply as the disease advances.
- It is not depression. Depression is a disorder of mood. Apathy is a disorder of initiation, and the person is usually not suffering the way a depressed person suffers.
- The circuit that turns wanting into doing is physically damaged. He has not stopped caring; the machinery that converts caring into movement has broken.
- The most useful test: in apathy, the person will often take part and even enjoy it once somebody else starts the activity. That is not stubbornness giving way. That is a missing start signal being supplied from outside.
- No drug is approved for apathy. Exercise and music have the most consistent evidence, and antidepressants can make it worse.
Is this depression?
Usually not, and the distinction changes what you do about it. Depression is a disorder of mood. Apathy is a disorder of motivation, and they respond to different things.
The two get confused constantly, including by clinicians, because they share a surface: loss of interest, slowed movement, a person who no longer does what they used to do.
Underneath they look different. Depression brings sadness, hopelessness, guilt, rumination, sometimes thoughts of not wanting to be here. Apathy brings none of that reliably. What it brings is a flattening — diminished initiative, diminished interest, diminished emotional response to good news and bad news alike.
The part families find hardest to believe is that the apathetic person is often not unhappy. The distress is in the room, but it is not usually in them. You are the one grieving. He is comfortable in the chair.
They can also occur together, and often do. This is not a reason to guess — it is a reason to say to the clinician, explicitly, "I am not sure whether this is low mood or loss of drive," because that sentence points at a different assessment than "he seems depressed."
So what is apathy, exactly?
A sustained reduction in goal-directed activity compared with how the person used to be, lasting at least four weeks, showing up in at least two of three areas: doing, feeling, and relating.
Consensus diagnostic criteria published in 2021 define it as a measurable drop in goal-directed activity relative to the person's own previous level, present for at least four weeks, affecting at least two of the following:
- Initiative — no longer starts activities, tasks or conversations without prompting.
- Emotion — reduced emotional expression or responsiveness, to good events as well as bad.
- Social engagement — no longer initiates contact, reaches out, or joins in.
And it has to be causing real impairment, and not be explained by physical disability, sedation, or a substance.
Around half of people with Alzheimer's have it. One large study tracked it against disease severity and found it in roughly 48 percent at the mildest stage, 74 percent at the moderate stage, and 82 percent at the severe stage. It runs high in Lewy body dementia, and in frontotemporal dementia it is close to universal — high enough that it forms part of the diagnostic picture.
It is also the most persistent neuropsychiatric symptom. Agitation flares and settles. Apathy does not spike; it grinds.
Why can't he just decide to get up?
Because deciding and starting are different operations in the brain, and it is the starting that has been damaged.
Goal-directed action depends on circuits running between the frontal lobes and structures deep in the brain — the anterior cingulate, the orbitofrontal cortex, the ventral striatum, and the dopamine pathways connecting them. Those circuits generate the start signal, sustain effort, and switch between tasks.
In dementia those circuits take damage. Apathy severity tracks measurable pathology in them: tangle density in the anterior cingulate, loss of gray matter in frontal regions, reduced blood flow and reduced metabolism in the same areas.
That distinction matters because the alternative explanations — he is being difficult, he has given up, he does not care anymore — are all accusations. They are also wrong, and they will poison months of your relationship if you believe them.
Does it mean the dementia is getting worse?
Apathy is associated with faster decline and worse function, and it often shows up early — sometimes before the diagnosis.
In people with mild cognitive impairment, apathy is associated with a significantly higher rate of progression to dementia. In cognitively normal older adults it predicts later impairment. It also predicts loss of everyday function: in one longitudinal study, apathy at baseline was associated with substantially greater odds of decline in the practical skills of daily life within a year.
It has been linked with higher mortality in nursing home residents, independent of depressive symptoms — though only a small number of studies have looked, so treat that as a signal rather than a settled fact.
None of that means apathy is causing the decline. It may simply be an early visible marker of where the disease has reached. But it is a reason to raise it with a clinician rather than absorbing it as a personality change.
What actually helps?
Exercise and music have the most consistent evidence. Most other things have been tried and produced mixed results, and the honest summary is that nothing works reliably.
A 2026 systematic review pulled together 62 randomized trials of non-drug approaches to apathy. Only 30 of them showed a significant benefit over the comparison group. Physical exercise and music-based interventions came out most consistent. Nothing proved superior overall, and effects were often short-lived.
That is a thinner evidence base than caregivers are usually told, and it is worth knowing before you blame yourself for a program that did not work.
What follows from the biology, and from expert consensus rather than trial data:
- Supply the start signal. Do not ask "do you want to go for a walk." Put his coat on and open the door. The question requires initiation; the action does not.
- Do it alongside him, not at him. Instruction is a demand for self-starting. Company is a shared start. In one large trial, reviewing and reducing antipsychotics on its own made apathy worse — it only improved when paired with social interaction or exercise. Another person in the room appears to be part of the mechanism.
- Break it into steps. One instruction at a time, each one small enough to be completed without holding a plan in mind.
- Lower the bar. Folding towels counts. Sitting in the garden counts. Listening to a record counts. The measure is engagement, not achievement.
- Use his best hours. Standard clinical advice rather than trial-proven, but costs nothing.
Do medications work?
No drug is approved for apathy. Methylphenidate has the best evidence and the results are genuinely mixed. Antidepressants can make it worse.
Methylphenidate is the most-studied option. The large ADMET 2 trial gave 200 people with Alzheimer's 20 mg a day for six months. On the apathy scale, the drug beat placebo by a small but statistically real margin. On the other co-primary measure — a clinician's overall impression of improvement — it did not reach significance. And there was no measurable difference in daily function, dependence, or quality of life.
Read honestly, that is a real but modest effect on the symptom, with no demonstrated effect on the life. Some people respond well and some do not, and there is currently no way to tell in advance. It is worth a conversation with a prescriber, with clear agreement about what you are hoping to see and when you will stop if you do not see it.
Cholinesterase inhibitors — donepezil and its relatives — have not been shown to reliably improve neuropsychiatric symptoms including apathy.
Antidepressants deserve a warning. SSRIs can produce an apathy and emotional-blunting syndrome of their own. It is dose-dependent and reverses when the dose comes down. If the flatness began or worsened after an antidepressant was started or increased, that is worth raising with the prescriber — particularly since the antidepressant may well have been started for the apathy in the first place.
Antipsychotics are not a treatment for apathy.
How do I live with this?
By grieving the relationship honestly, and by stopping the argument you cannot win.
Caregivers of people with apathy report more distress and fewer of the good moments than caregivers dealing with other symptoms. The reason is specific and worth naming: the caregiving continues, but the relationship stops answering back. You bring him tea, and nothing comes back across the table.
A study interviewing carers living with this found them caught in a bind you may recognize — wanting to include the person in decisions about his own day, and discovering that including him means nothing happens at all. Getting past the apathy and respecting his autonomy pull in opposite directions, every morning.
Some things that make it survivable:
- Stop asking open questions. "What would you like to do today?" is unanswerable for him and demoralizing for you.
- Let go of persuasion. He cannot be talked into initiating. That conversation only produces frustration on both sides.
- Count engagement, not enthusiasm. He sat outside for twenty minutes. That happened. It is not nothing.
- Name it to other people. Family who visit rarely will read the flatness as rejection or as depression, and will tell you he needs cheering up. Tell them what it actually is.
Frequently asked questions
Is apathy in dementia the same as depression?
Is he just being lazy or giving up?
Will antidepressants help apathy?
Is there a medication for apathy in dementia?
What activities work for someone with apathy?
Does apathy mean the dementia is progressing?
You shouldn't be carrying this by yourself.
Day to Day Dementia is a place to say the hard things to people who have heard them before and won't flinch. Join the waitlist and we'll let you know when the doors open.
Become a founding memberSources
- Zhao QF, Tan L, Wang HF, et al. "The prevalence of neuropsychiatric symptoms in Alzheimer's disease: systematic review and meta-analysis." *Journal of Affective Disorders*, 2016.
- Miller DS, Robert P, Ereshefsky L, et al. "Diagnostic criteria for apathy in neurocognitive disorders." *Alzheimer's & Dementia*, 2021.
- Lanctôt KL, Ismail Z, Bawa KK, et al. "Distinguishing apathy from depression: a review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders." *International Journal of Geriatric Psychiatry*, 2023.
- Grossman HT, Sano M, Aloysi A, et al. "Prevalent, persistent, and impairing: longitudinal course and impact of apathy in Alzheimer's disease." *Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring*, 2021.
- Fresnais D, Humble MB, Bejerot S, Meehan AD, Fure B. "Apathy as a predictor for conversion from mild cognitive impairment to dementia: a systematic review and meta-analysis of longitudinal studies." *Journal of Geriatric Psychiatry and Neurology*, 2023.
- Nijsten JMH, Leontjevas R, Pat-El R, et al. "Apathy: risk factor for mortality in nursing home patients." *Journal of the American Medical Directors Association*, 2017.
- Christidi F, et al. "Non-Pharmacological Interventions for Managing Apathy in Older Adults with Neurocognitive Disorders: A Systematic Review of Randomized Controlled Trials." *Brain Sciences*, 2026.
- Mintzer J, Lanctôt KL, Scherer RW, et al. "Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial." *JAMA Neurology*, 2021.
- Masdrakis VG, Markianos M, Baldwin DS. "Apathy associated with antidepressant drugs: a systematic review." *Acta Neuropsychiatrica*, 2023.
- Ballard C, Orrell M, Sun Y, et al. "Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life, and mortality in people with dementia living in nursing homes (WHELD)." *Journal of the American Medical Directors Association*, 2016.
- Manera V, Robert P, et al. "Recommendations for the Nonpharmacological Treatment of Apathy in Brain Disorders." *American Journal of Geriatric Psychiatry*, 2020.
- Baber W, Chang CYM, Yates J, Dening T. "'He just doesn't want to get out of the chair and do it': the impact of apathy in people with dementia on their carers." *International Journal of Environmental Research and Public Health*, 2021.